School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil.
Department of Basic Pathology, Federal University of Paraná, Curitiba, Brazil.
J Clin Ultrasound. 2022 Mar;50(3):326-338. doi: 10.1002/jcu.23160. Epub 2022 Feb 26.
COVID-19 is a dynamic disease and may affect different tissues and organs as it progresses. Therefore, the impact generated by the disease in all its stages and organs requires a functional and versatile imaging technique able to detect particularities or artifacts dynamically. Ultrasonography fulfills all these requirements and exhibit several advantages relative to other imaging modalities, including portability, lower cost and biosafety. Throughout the COVID-19 pandemic, ultrasonography displayed a crucial role in the triage, monitoring, indicating organ damages and enabling individualized therapeutical decisions in COVID-19 patients. This review is dedicated to highlight the main pathological effects correlated with ultrasound changes caused by COVID-19 in the lungs, heart and liver.
COVID-19 是一种动态疾病，随着病情的发展，可能会影响不同的组织和器官。因此，该疾病在所有阶段和器官中产生的影响需要一种功能多样的成像技术，以便能够动态检测到特殊性或伪影。超声检查满足了所有这些要求，并且相对于其他成像方式具有多项优势，包括便携性、成本更低和生物安全性。在整个 COVID-19 大流行期间，超声检查在 COVID-19 患者的分诊、监测、提示器官损伤以及实现个体化治疗决策方面发挥了关键作用。本综述旨在重点介绍与 COVID-19 引起的肺部、心脏和肝脏超声变化相关的主要病理影响。
